XWXueqin Wang

Xueqin Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xueqin Wang has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Chuan Shi

    Peking University Sixth Hospital, Peking University Institute of Mental Health, Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing, China

    1 shared publication
  • Daomin Zhu

    Department of Sleep Medicine Fourth People's Hospital of Hefei Affiliated Psychological Hospital of Anhui Medical University Hefei China

    1 shared publication
  • Feng Geng

    Department of Psychiatry The Second Affiliated Hospital of Anhui Medical University Hefei China

    1 shared publication
  • Guizhong Yao

    Peking University Sixth Hospital, Peking University Institute of Mental Health, Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing, China

    1 shared publication
  • Hongyu Tang

    Peking University Sixth Hospital, Peking University Institute of Mental Health, Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing, China

    1 shared publication
  • Jie Sun

    Department of Pain Peking University Third Hospital Peking University Beijing China

    1 shared publication

Latest Publications

  • Fecal microbiota transplantation‐based treatment protocol for chronic insomnia disorder: A randomized, double‐blind, placebo‐controlled trial

    by Teng Gao, Xiaoxing Liu, Weifeng Mi, Le Shi, Xueqin Wang, Daomin Zhu, Feng Geng, Yixiao Fu, Yongfeng Yang, Xinrong Li, et al.

    Objective: Chronic insomnia disorder is common and burdensome, and current treatments remain limited. We conducted a multicenter, randomized, double‐blind, placebo‐controlled trial to determine whether a fecal microbiota transplantation (FMT)‐based treatment protocol improves sleep outcomes in adults with chronic insomnia disorder. Methods: Participants were randomly assigned 1:1 to receive short‐course antibiotic pretreatment followed by donor microbiota capsules ( n = 40) or placebo capsules without antibiotic pretreatment ( n = 40). Within each group, participants were further randomized to receive synbiotic supplementation or matched placebo for prespecified exploratory subgroup analyses. The primary outcome was polysomnography‐measured sleep efficiency (SE) at 1 month after treatment. Secondary outcomes included other polysomnographic parameters, patient‐reported sleep outcomes, and safety; microbiota analyses were exploratory. Results: Compared with placebo, the FMT‐based treatment protocol improved SE (adjusted between‐group difference, 13.9 percentage points; 95% CI 7.29–20.41; p = 0.003) and reduced wake after sleep onset. Synbiotic assignment did not suggest meaningful differences in SE. Insomnia Severity Index and Pittsburgh Sleep Quality Index scores showed sustained improvement from 2 to 6 months. Treatment was well tolerated, with mild, self‐limited adverse events and no serious adverse events. The intervention increased microbial richness and diversity and altered community structure; responders and non‐responders showed similar posttreatment β ‐diversity change but differed in baseline microbiota composition. Conclusion: In adults with chronic insomnia disorder, an FMT‐based treatment protocol incorporating antibiotic pretreatment improved objective sleep continuity and sustained subjective insomnia outcomes. Baseline microbial composition may contribute to treatment heterogeneity and merits further investigation.

  • Longitudinal informed consent competency in stable community patients with schizophrenia: A one-week training and one-year follow-up study

    by Xueqin Wang, Xin Yu, Paul S. Appelbaum, Hongyu Tang, Guizhong Yao, Tianmei Si, Yating Ma, Tao Li, Ling Yu, Chuan Shi, et al.